The emerging role of histologic disease activity assessment in ulcerative colitis  Rish K. Pai, MD, PhD, Vipul Jairath, MD, PhD, Niels Vande Casteele,

Slides:



Advertisements
Similar presentations
Representative hematoxylin-eosin stained (HE) sections demonstrating immune checkpoint inhibition-related colitis representative HE sections demonstrating.
Advertisements

Ulcerative Colitis Mayo Clinic Proceedings
Surveillance of Dysplasia in Inflammatory Bowel Disease: The Gastroenterologist- Pathologist Partnership  David T. Rubin, Jerrold R. Turner  Clinical Gastroenterology.
Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report  Philip V. Hassard, Scott W. Binder, Viera.
Outcome analysis in Crohn’s disease using endomicroscopy: How important and reliable is in vivo analysis of microscopic changes?  Ralf Kiesslich, MD,
Kulwinder S. Dua, MD, Joseph Merrill, MD  Gastrointestinal Endoscopy 
Diverticular Disease–Associated Segmental Colitis
Malabsorption Work-up: Utility of Small Bowel Biopsy
Optical biopsy for colorectal polyps: moving along the S-shaped curve
Illicit Drug, Ischemic Bowel
Terry L. Jue, MD  Gastrointestinal Endoscopy 
Adult Autoimmune Enteropathy: Mayo Clinic Rochester Experience
Association Between Ipilimumab and Celiac Disease
Dasatinib-Induced Colitis after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia  Ibrahim Aldoss,
A randomized study to evaluate the effect of a perioperative infusion of dopexamine on colonic mucosal ischemia after aortic surgery  Mohamed S. Baguneid,
Ulcerative Colitis Mayo Clinic Proceedings
Yngvar Fløisand, Knut E. A
Laurent Peyrin–Biroulet, Aude Bressenot, Wendy Kampman 
Recurrent Pancreatitis, Rash, and Diarrhea: Crohn's Disease
Yoji Ishizu, MD, PhD, Masatoshi Ishigami, MD, PhD 
Intestinal Inflammation and Cancer
Distribution of Body Fat and Its Influence on Esophageal Inflammation and Dysplasia in Patients With Barrett's Esophagus  Eric M. Nelsen, Yujiro Kirihara,
Ian R. Gooding, Roger Springall, Ian C. Talbot, David B.A. Silk 
Beyond Standard Image-enhanced Endoscopy Confocal Endomicroscopy
Gastrointestinal Endoscopy
Thomas M. Runge, MD, MPH  Gastrointestinal Endoscopy 
Tonya Kaltenbach, MD, William J. Sandborn, MD 
Barriers to colonoscopy among New York City homeless
Andres F. Carrion, MD  Gastrointestinal Endoscopy 
Surgery versus surveillance in ulcerative colitis patients with endoscopically invisible low-grade dysplasia: a cost-effectiveness analysis  Ben Parker,
Diagnosis of Colitis: Making the Initial Diagnosis
Quality improvement for the gastroenterology fellow
Roxana M. Coman, MD, PhD  Gastrointestinal Endoscopy 
Volume 4, Issue 3, Pages (March 2019)
Nadeem Hussain, Martha Quezado, Marjan Huizing, David Geho, James G
Volume 129, Issue 1, Pages (July 2005)
Sergey V. Kantsevoy, MD, PhD  Gastrointestinal Endoscopy 
Microscopic Colitis Gastroenterology
Ischemic colitis during treatment with alosetron
Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement?  James J. Farrell, MD  Gastrointestinal Endoscopy 
Postcolonoscopy mortality: Bowel preparation to blame?
Sergey V. Kantsevoy, MD, PhD  Gastrointestinal Endoscopy 
An unusual presentation of anisakiasis in the colon (with video)
Use of diphenhydramine as an adjunctive sedative for colonoscopy in patients on chronic opioid therapy: a randomized controlled trial  Salman Nusrat,
David L. Diehl, MD, FACP, FASGE, Jay P. Babich, MD 
Much ado about very little (lamina propria)?
What is the optimal treatment for hepatic abscess and infected biloma?
Worrisome endoscopic feature in the stomach of patients with familial adenomatous polyposis: the proximal white mucosal patch  Nitin Das Kunnathu, MD 
Gregory G. Ginsberg, MD  Gastrointestinal Endoscopy 
Endoscopic sleeve gastroplasty for obesity: defining the risk and reward after more than 1600 procedures  Andrew C. Storm, MD, Barham K. Abu Dayyeh, MD,
Amebic colitis simulating ulcerative colitis
Volume 4, Issue 5, Pages (May 2019)
Endoscopic placement of video capsule in a pediatric population
Endoscopic appearance of duodenal mucosa in GI leishmaniasis
Gavin C. Harewood, MD, FRCPI, MSc  Gastrointestinal Endoscopy 
Confocal microscopy from the bench to the bedside
David S. Fefferman, Richard J. Farrell 
Argon plasma coagulation: Clinical experience in pediatric patients
Inadequate colonoscopy preparation: Is it time to send out an SMS?
Mucosal scars in collagenous colitis
Endoscopic band ligation of colonic bleeding
Neil O'Morain, Ammar Shahin, Barbara Ryan, Deirdre McNamara 
William Berquist, MD  Gastrointestinal Endoscopy 
Interventional chromoendoscopy: specific aspects for the colon
Enteral stents: from esophagus to colon
Deeper and deeper into the pediatric small bowel
Kimitoshi Kato, MD  Gastrointestinal Endoscopy 
Hard to swallow: colonic adenocarcinoma in esophagus
Rapid intraluminal growth of a colorectal cancer observed by endoscopy
Overtube-assisted endoscopic application of oxidized cellulose to achieve hemostasis in anastomotic ulcer bleeding  Matthew Skinner, MD, Jacobo Velazquez-Avina,
Presentation transcript:

The emerging role of histologic disease activity assessment in ulcerative colitis  Rish K. Pai, MD, PhD, Vipul Jairath, MD, PhD, Niels Vande Casteele, PharmD, PhD, Florian Rieder, MD, Claire E. Parker, MLIA, MA, Gregory Y. Lauwers, MD  Gastrointestinal Endoscopy  Volume 88, Issue 6, Pages 887-898 (December 2018) DOI: 10.1016/j.gie.2018.08.018 Copyright © 2018 American Society for Gastrointestinal Endoscopy Terms and Conditions

Figure 1 Endoscopic measurements of disease activity in UC. A, Normal endoscopic appearance (MES = 0). B, Mild endoscopic disease characterized by erythema and loss of vascular pattern (MES = 1). C, Moderate disease with friability and erosions (MES = 2). D, Severe endoscopic disease with spontaneous bleeding and ulceration (MES = 3). Gastrointestinal Endoscopy 2018 88, 887-898DOI: (10.1016/j.gie.2018.08.018) Copyright © 2018 American Society for Gastrointestinal Endoscopy Terms and Conditions

Figure 2 Endoscopic and histologic findings from a patient in clinical remission. A, Colonoscopy demonstrated unremarkable colonic mucosa (MES = 0). B, A colonic biopsy demonstrated active disease characterized by neutrophilic cryptitis (arrow). Gastrointestinal Endoscopy 2018 88, 887-898DOI: (10.1016/j.gie.2018.08.018) Copyright © 2018 American Society for Gastrointestinal Endoscopy Terms and Conditions

Figure 3 Spectrum of histologic disease seen in ulcerative colitis. A, Representative biopsy from a patient with active ulcerative colitis. This biopsy fragment demonstrates crypt architectural distortion, neutrophil-mediated epithelial injury (cryptitis and crypt abscesses), and basal plasmacytosis (characterized by dense plasma cells separating colonic crypts from the muscularis mucosae). B, Severe histologic activity with ulceration characterized by granulation tissue with associated neutrophilic inflammation. C, A biopsy demonstrating chronic active colitis without basal plasmacytosis. There is crypt atrophy and scattered foci of neutrophilic cryptitis (arrows). D, A colonic biopsy fragment with increased lamina propria eosinophils. Gastrointestinal Endoscopy 2018 88, 887-898DOI: (10.1016/j.gie.2018.08.018) Copyright © 2018 American Society for Gastrointestinal Endoscopy Terms and Conditions

Figure 4 Proposed histologic targets in ulcerative colitis. A, Histologic normalization. B, Histologic quiescence without basal plasmacytosis or increased lamina propria eosinophils. C, Histologic quiescence with basal plasmacytosis. D, Histologic near remission characterized by rare neutrophilic crypts (arrow) and absence of basal plasmacytosis. Gastrointestinal Endoscopy 2018 88, 887-898DOI: (10.1016/j.gie.2018.08.018) Copyright © 2018 American Society for Gastrointestinal Endoscopy Terms and Conditions